Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)
CNY 14.79
(-0.47%)
CNY 14.79
(-0.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.75 Billion | 2.2 Billion | 1.59 Billion | 1.31 Billion | 1.51 Billion | 1.39 Billion |
| Cost of Revenue | 2.1 Billion | 1.69 Billion | 1.22 Billion | 858.18 Million | 999.41 Million | 1.02 Billion |
| Gross Profit | 649.41 Million | 504.68 Million | 367.13 Million | 461.47 Million | 511.44 Million | 378.53 Million |
| Operating Expenses | 244.73 Million | 197.37 Million | 156.08 Million | 115.65 Million | 215.08 Million | 160.15 Million |
| Selling, General and Administrative Expenses | 127.85 Million | 58.24 Million | 48.47 Million | 35.99 Million | 122.15 Million | 88.21 Million |
| Research and Development Expenses | 124.27 Million | 99.71 Million | 84.22 Million | 65.03 Million | 53.79 Million | 43.91 Million |
| Other Expenses | -7.39 Million | 39.41 Million | 23.38 Million | 14.62 Million | 39.13 Million | -29.79 Thousand |
| Cost and Expenses | 2.35 Billion | 1.89 Billion | 1.38 Billion | 973.83 Million | 1.21 Billion | 1.18 Billion |
| Operating Income | 427.08 Million | 349.23 Million | 256.64 Million | 356.11 Million | 310.53 Million | 224.3 Million |
| Interest Expense | 37.14 Million | 14.23 Million | 3.89 Million | 8.44 Million | 12.15 Million | 14.97 Million |
| Income Tax Expense | 50.01 Million | 23.5 Million | 17.36 Million | 41.35 Million | 37.93 Million | 25.25 Million |
| Earnings before Tax | 422.4 Million | 342.78 Million | 254.06 Million | 348.51 Million | 308.05 Million | 224.63 Million |
| Net Income | 371.45 Million | 319.27 Million | 236.7 Million | 307.16 Million | 270.11 Million | 199.37 Million |
| Earnings Per Share Basic | 1.63 | 1.40 | 1.04 | 1.34 | 1.18 | 1.21 |
| Earnings Per Share Diluted | 1.63 | 1.40 | 1.04 | 1.34 | 1.18 | 1.21 |
| Weighted Average Shares Outstanding | 228.45 Million | 228.45 Million | 228.45 Million | 228.45 Million | 228.45 Million | 164.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 228.45 Million | 228.45 Million | 228.45 Million | 228.45 Million | 228.45 Million | 164.88 Million |
| Gross Margin | 0.24 | 0.23 | 0.23 | 0.35 | 0.34 | 0.27 |
| EBIT Margin | 0.23 | 0.21 | 0.22 | 0.31 | 0.25 | 0.21 |
| Profit Margin | 0.13 | 0.15 | 0.15 | 0.23 | 0.18 | 0.14 |
| EBITDA | 630.76 Million | 463.49 Million | 343.18 Million | 415.65 Million | 350.53 Million | 275.69 Million |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.16 | 0.27 | 0.21 | 0.16 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 747.06 Million | 718.22 Million | 628.58 Million | 732.69 Million | 2.75 Billion | 673.29 Million |
| Cost of Revenue | 601.25 Million | 586.47 Million | 482.35 Million | 566.44 Million | 2.12 Billion | 502.88 Million |
| Gross Profit | 145.8 Million | 131.74 Million | 146.23 Million | 166.24 Million | 633.47 Million | 170.41 Million |
| Operating Expenses | 83.29 Million | 84.03 Million | 70.27 Million | 73.73 Million | 238.16 Million | 61.99 Million |
| Selling, General and Administrative Expenses | 101.56 Million | 52.25 Million | 38.75 Million | 44.12 Million | - | 51.04 Million |
| Research and Development Expenses | 29.9 Million | 31.78 Million | 31.17 Million | 27.78 Million | - | 36.04 Million |
| Other Expenses | -48.17 Million | 3620.00 | -336.35 Thousand | -1.82 Million | 2.51 Million | 7.22 Million |
| Cost and Expenses | 684.54 Million | 670.51 Million | 552.62 Million | 640.17 Million | 2.36 Billion | 564.87 Million |
| Operating Income | 48.75 Million | 47.71 Million | 75.96 Million | 92.51 Million | 395.3 Million | 107.15 Million |
| Interest Expense | 7.33 Million | 8.14 Million | 9.85 Million | 10.06 Million | 37.14 Million | 10.32 Million |
| Income Tax Expense | -1.49 Million | 2.1 Million | 5.56 Million | 15.49 Million | 50.01 Million | 17.58 Million |
| Earnings before Tax | 47.37 Million | 58.08 Million | 81.78 Million | 111.71 Million | 411.22 Million | 107.54 Million |
| Net Income | 48.53 Million | 58.38 Million | 79.99 Million | 96.69 Million | 371.45 Million | 89.57 Million |
| Earnings Per Share Basic | 0.17 | 0.20 | 0.35 | 0.42 | - | 0.39 |
| Earnings Per Share Diluted | 0.11 | 0.17 | 0.28 | 0.42 | - | 0.39 |
| Weighted Average Shares Outstanding | 285.49 Million | 296.99 Million | 228.45 Million | 228.45 Million | 228.45 Million | 228.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 441.21 Million | 334.34 Million | 285.7 Million | 228.45 Million | 228.45 Million | 228.45 Million |
| Gross Margin | 0.20 | 0.18 | 0.23 | 0.23 | 0.23 | 0.25 |
| EBIT Margin | 0.07 | 0.13 | 0.16 | 0.19 | - | 0.18 |
| Profit Margin | 0.06 | 0.08 | 0.13 | 0.13 | 0.13 | 0.13 |
| EBITDA | 54.7 Million | 95.84 Million | 97.87 Million | 138.54 Million | - | 118.58 Million |
| Earnings Before Tax Margin | 0.07 | 0.07 | 0.12 | 0.13 | 0.14 | 0.16 |
BRAU
GGIFF
603811
SMFIL
EAWD
600298